Biotech VC Funds

Endiya Partners, founded in 2015 and based in Hyderabad, India, is an early-stage venture capital firm focusing on deep tech, healthcare, and enterprise technology. The firm is known for its significant contributions to the startup ecosystem, particularly in supporting innovative and scalable businesses. Endiya's portfolio includes a variety of notable investments. For instance, Darwinbox, a comprehensive HR management platform; Kissht, a consumer credit platform; and Cult.fit, a health and wellness company. Additionally, their investments in the healthcare sector include SigTuple, which utilizes AI for medical diagnostics, and EKincare, a health benefits platform offering preventive and personalized healthcare services. The firm has seen successful exits such as ShieldSquare, acquired by Radware, and Steradian Semiconductors, acquired by Renesas. Endiya Partners has been actively deploying its second fund, which closed at $75 million in 2021, to continue supporting promising startups. Key team members include co-founders Sateesh Andra, Ramesh Byrapaneni, and Abhishek Srivastava, who bring extensive industry experience and a strong network to help their portfolio companies grow and succeed.

Endure Capital, founded in 2015 by Tarek Fahim, is an early-stage investment fund based in Cairo, Egypt. The firm focuses on investing in startups across various sectors, including technology, healthcare, fintech, and foodtech. With an asset under management (AUM) of $85 million, Endure Capital has invested in 52 companies and has had significant exits, including Careem, which was acquired by Uber for $3.1 billion. The firm's notable investments include regional leaders like MaxAB, a B2B e-commerce platform, and Breadfast, a pioneering grocery delivery startup. Internationally, their portfolio features companies like Boom Supersonic and Aspect Biosystems. Endure Capital typically invests in pre-seed, seed, Series A, and Series B rounds, with ticket sizes ranging from $1 million to $5 million. Endure Capital recently closed the first round of its $50 million fund, Endure 21, aimed at impact-driven early-stage startups in Africa and selectively investing in growth-stage startups globally. The firm is expanding its reach into North America and Saudi Arabia, launching the Arak Fund in partnership with Awaed Capital, which focuses on various advanced sectors including space technology and AI infrastructure. Endure Capital also emphasizes long-term support and mentorship for its portfolio companies through initiatives like “Endure... Pay it Forward,” reflecting its commitment to nurturing a vibrant startup ecosystem.

Energize Ventures, now rebranded as Energize Capital, is a premier venture capital firm based in Chicago, focusing on accelerating the sustainable energy transition through digital innovation. Established in 2016, Energize manages over $700 million in assets and specializes in funding software solutions at the intersection of renewable energy, industrial operations, mobility, and infrastructure resilience. Notable investments from Energize Capital include companies like DroneDeploy, a leading drone software platform; Jupiter Intelligence, which provides predictive analytics for climate risk; and Nozomi Networks, a cybersecurity firm specializing in industrial control systems. Their portfolio highlights their commitment to advancing technologies that support decarbonization and critical infrastructure. Energize Capital typically invests in both early and growth-stage companies, with investment amounts ranging from $5 million to $15 million. They often lead funding rounds, providing not just capital but also operational and strategic support to help scale their portfolio companies. Recent significant investments include PVcase, a solar design software, and Monta, an EV charging platform. The firm's geographic focus primarily covers North America and Europe, leveraging a network of institutional investors such as Invenergy, CDPQ, and GE Renewable Energy. Energize’s team includes industry veterans like John Tough, Managing Partner, who brings extensive experience in power and renewables. Energize Capital prefers to be approached by startups with proven market potential and strong leadership teams. They are particularly interested in companies driving digital transformation in the energy sector, aiming to identify and support the most promising technologies for a sustainable future.

ENGIE New Ventures, established in 2014, is the corporate venture capital arm of ENGIE, a global energy leader. With a +€250 million fund, ENGIE New Ventures focuses on cleantech startups that are advancing the transition to a sustainable, decentralized, and digitalized energy system. The firm invests in Series A and B stages, supporting companies that have proven technologies and are ready to scale. ENGIE New Ventures collaborates closely with its portfolio startups, offering not only capital but also access to ENGIE’s global market connections, technical expertise, and customer base​. The fund targets a broad range of sectors within the clean energy space, including renewable energy, low-carbon hydrogen, decarbonization of thermal energy, and energy management solutions. It seeks startups that present innovative technologies, unique customer solutions, or novel business models that align with ENGIE’s mission. ENGIE New Ventures has made over 50 strategic investments worldwide, with a diverse portfolio that includes companies like H2SITE, which focuses on decentralized hydrogen production, and Heliatek, a producer of organic solar films. The firm maintains long-term partnerships with its startups, ensuring they have the support needed to grow globally. By driving innovation in cleantech, ENGIE New Ventures is playing a key role in accelerating the global energy transition.

Eni is a leading global energy company headquartered in Rome, Italy, with operations in over 60 countries. As one of the world's "supermajors," Eni is involved in the entire energy value chain, from the exploration and production of oil and natural gas to refining, marketing, and the generation of electricity. The company is heavily investing in the energy transition, aiming to achieve carbon neutrality by 2050. Eni's strategic focus includes expanding its renewable energy portfolio, developing sustainable mobility solutions, and implementing circular economy practices. For example, through its subsidiary Plenitude, Eni is rapidly growing its renewable energy capacity, with a goal of exceeding 7 GW by 2026. The company is also enhancing its presence in the biorefining sector, integrating green technologies into its operations to reduce its environmental footprint. Financially, Eni remains robust, with plans to invest around €37 billion between 2023 and 2026, including significant allocations toward low-carbon and zero-carbon projects. The company is also committed to returning value to its shareholders through dividends and share buybacks, driven by strong cash flow from its diverse business segments. Eni's global operations, particularly in regions like Africa and the Middle East, contribute to its strategic goals of energy diversification and supply security, while also supporting local economic development​.

Eniac Ventures is a premier seed-stage venture capital firm with a notable portfolio including Hinge, Headspace, and Tapad. Focused on AI, SaaS, healthcare, and deep tech, Eniac invests primarily in U.S.-based companies. The firm typically leads seed rounds with average check sizes ranging from $500K to $1M, and is renowned for its hands-on approach and strategic support. Co-founders Hadley Harris and Nihal Mehta leverage their extensive entrepreneurial backgrounds to guide startups towards success. Eniac prefers pitches that demonstrate strong technical foundations and significant market potential. They have been especially active recently, seeking bold, transformative startups that can redefine their industries. For founders, a warm introduction and a well-prepared, concise pitch are key to gaining their attention. Eniac’s team is dedicated to fostering innovation and driving growth, positioning themselves as valuable partners in the startup ecosystem.

EnjoyVenture GmbH is a Dusseldorf-based venture capital firm founded in 2000 with a focus on life sciences and technology. The firm manages approximately €160 million across its third generation of funds and has invested in more than 200 startups since founding, making it one of Germany's most prolific seed investors. EnjoyVenture leads rounds and backs companies at Pre-seed and Seed stages with checks typically in the $100,000 to $2 million range. The portfolio of 200 investments spans software, healthtech, biotech, AI and deep tech, SaaS, e-commerce, hardware, data analytics, and clean technology. The firm's portfolio includes one unicorn, Grover, a device-as-a-service platform, and 9 acquisitions including GridScale and VoiceObjects. EnjoyVenture's interdisciplinary investment team consists of 13 business professionals, 5 industrial engineers, and 1 lawyer, giving it an unusually broad set of domain capabilities across both technology and life sciences sectors. EnjoyVenture operates with topic and region-specific investment criteria across its seed fund products, allowing it to match capital and expertise to particular verticals. The firm primarily focuses on German and broader European startups, with a track record built over 25 years of backing early-stage founders across diverse technology sectors. The combination of deep life sciences knowledge and broad technology investment experience positions EnjoyVenture as a generalist seed champion within the German-speaking venture landscape.

Enso Ventures is a private investment firm founded in 2010, with offices in London and New York. The firm focuses on selective equity investments in high-technology and biotechnology companies, particularly in Europe and the United States. Enso Ventures leverages its industry expertise and capital to accelerate the commercial development of startup companies in fields like materials technology and life sciences. Enso Ventures typically participates in Series A rounds and later, with an average round size of around $6 million. The firm has built a portfolio of 15 companies, with 7 successful exits to date. Notable investments include companies like Cavion, which focuses on innovative pharmaceutical solutions, NeuroVia, specializing in drug discovery, and Seres Therapeutics, a leader in biotechnology. Enso Ventures aims to back startups that are poised to drive significant advancements in their industries, with a focus on developing disruptive technologies in both the biotech and materials tech sectors.

Entrada Ventures is an early-stage venture capital firm based in California, with offices in Santa Barbara and Silicon Valley. The firm primarily focuses on investing in enterprise and industrial technology startups, particularly those with innovative solutions that address some of the world's most challenging problems. With over two decades of experience, Entrada Ventures is known for its hands-on approach, working closely with founders to navigate critical strategic decisions and solve tactical challenges throughout the lifecycle of their companies. Entrada's investment strategy emphasizes building long-term partnerships with visionary teams, particularly in sectors like AI, quantum computing, cybersecurity, and advanced materials. Their portfolio includes companies like Kipu Quantum, which is pioneering quantum computing for industrial applications, and Coreshell, which focuses on advancing battery technology. The firm prides itself on its deep connection to the Central Coast region but also extends its reach globally, leveraging a network of world-class research ecosystems to drive unique deal flow. Over the years, Entrada has supported numerous startups through various stages, helping them achieve significant milestones, including successful exits and IPOs. Their involvement goes beyond just financial backing, as they actively participate in helping startups connect with prospective teammates, customers, and top-tier follow-on investors.

Entrée Capital, a global venture capital firm founded in 2010, provides multi-stage funding for innovative startups from pre-seed to growth stages. They manage over $1.25 billion across nine funds, focusing heavily on fintech, deep tech, SaaS, AI, blockchain, and e-commerce sectors. Their notable investments include Monday.com, Coupang, Stripe, and Cazoo. Based in Tel Aviv, Israel, with additional offices in London and New York, Entrée Capital primarily targets investments in Israel, the U.S., and Europe. The firm’s strategy involves supporting startups from the idea stage through to scaling, providing both capital and strategic guidance. They actively lead funding rounds and offer extensive mentorship and market insights to help portfolio companies navigate growth challenges. Key team members include Aviad Eyal, co-founder and managing partner, and Eran Bielski, general partner. Both bring extensive experience in venture capital and entrepreneurship, contributing to the firm's strong track record of successful investments and exits. Entrée Capital has backed over 180 startups, achieving more than 27 exits and IPOs, and supporting over 17 unicorns. The firm’s approach emphasizes building strong, long-term relationships with founders and aligning closely with their visions. They are particularly accessible through direct contact on their website and prefer pitches that demonstrate clear, innovative business models and strong market potential.

Entrepreneur First (EF) is a global talent investor founded in 2011 by Alice Bentinck and Matt Clifford. EF's unique approach focuses on helping individuals build technology companies from scratch, often before they have a team or specific idea. This model emphasizes selecting ambitious individuals based on their potential and providing them with the resources to find co-founders and develop their startups. Operating in major cities such as London, Singapore, Berlin, Paris, Bangalore, and Toronto, EF has successfully created over 500 companies with a combined valuation exceeding $10 billion. Some of their most notable investments include Tractable, a computer vision company valued at $1 billion; Magic Pony Technology, which was acquired by Twitter for $150 million; and Omnipresent, a remote HR platform. EF typically invests around £80,000 in each startup in Europe, C$100,000 in Canada, and SG$75,000 in Asia, in exchange for a 10% equity share. Their portfolio boasts significant exits like Deliveroo, PassFort Limited, and Trussle, showcasing their effectiveness in nurturing early-stage startups. EF's investment philosophy prioritizes talent over pre-existing ideas, enabling them to partner with ambitious individuals early in their entrepreneurial journey. The firm has received backing from prominent figures and institutions, including Reid Hoffman, co-founder of LinkedIn, and John and Patrick Collison, co-founders of Stripe. This strong support system, coupled with EF's robust program, helps founders develop their ideas, find co-founders, and secure further investment from top-tier venture capital firms.

Entrepreneurs Roundtable Accelerator (ERA), founded in 2011, is New York City's leading technology accelerator and early-stage venture capital fund. ERA focuses on investing in startups at the forefront of various industries, including health care, financial services, future of work, commerce, and climate. ERA typically invests $150,000 in each company for a 6% stake through a post-money SAFE. The accelerator provides extensive support to its portfolio companies, including free office space, cloud hosting credits, and access to a network of over 1,000 expert mentors. This mentorship network is crucial in helping startups navigate the challenges of early-stage growth. Notable investments by ERA include Glia, TripleLift, Katapult, Thirty Madison, Nayya, Order, Bespoke Post, User Interviews, Fund That Flip, CardFlight, and Scentbird. ERA alumni companies have collectively raised over $2 billion in investor capital and exceed $10 billion in market capitalization. ERA is known for its robust support system, which includes talent acquisition, business development, community and networking, marketing, and PR. The accelerator's commitment to fostering innovation and entrepreneurship has positioned it as a pivotal player in New York's startup ecosystem​.

Envisioning Partners, based in Seoul, South Korea, is a leading impact-focused venture capital firm. Founded to address critical global challenges, the firm targets investments in startups that leverage technology and innovation to tackle climate change, improve health and wellness, enhance education, and transform the future of work. Envisioning Partners manages around $140 million in assets and invests primarily in pre-Series A to Series B stages, supporting companies with both capital and strategic guidance. The firm’s commitment to sustainability and social impact is reflected in its diverse portfolio. Envisioning has backed companies such as Shiok Meats (cell-cultured crustaceans), Mango Materials (biodegradable plastics), and H2 (vanadium redox flow batteries for long-duration energy storage). They have also invested in education and health-related startups like Enuma, which provides accessible learning solutions, and Caring, a platform for elderly care services. Envisioning Partners applies a rigorous impact discipline, aligning its investments with the United Nations Sustainable Development Goals (SDGs). The firm offers robust post-investment support through a global network of advisors and industry experts, helping its portfolio companies achieve both financial success and meaningful social impact​.

EPIC Ventures, based in Salt Lake City, Utah, is a venture capital firm that specializes in early-stage investments in technology sectors such as SaaS, healthcare, security, and fintech. Founded in 1994, EPIC Ventures has a long history of backing companies that are innovating in emerging markets. Some of their notable portfolio companies include Recursion Pharmaceuticals, Medsphere, and Health Catalyst, showcasing their strong focus on health and life sciences. The firm is also active in sectors like future of work and AI, with investments in xAI and Unlearn.AI. EPIC Ventures is known for its hands-on approach, providing not just capital but also strategic guidance and access to an extensive network of advisors. They work closely with the University of Utah through a joint venture called University of Utah Ventures, which focuses on supporting startups and commercialization efforts from academic research.

Epidarex Capital is a dynamic venture capital firm focusing on early-stage life science investments in under-ventured research hubs across the US and UK. The fund targets transformative opportunities in biotechnology, pharmaceuticals, medical devices, and health tech. Notable investments include Dunad Therapeutics, EM Imaging, and Leucid Bio. Established in 2010, Epidarex partners with leading universities and research institutions, providing crucial capital to spin out innovative technologies with the potential for significant patient impact and high financial returns. Their investment strategy prioritizes disruptive platform technologies addressing unmet medical needs, robust intellectual property portfolios, and early evidence of market validation. Epidarex is known for backing driven and tenacious founders, often providing seed or Series A funding. They maintain a rigorous evaluation process to ensure each investment has a sustainable competitive advantage and clear regulatory strategies. Epidarex's team, led by General Partner Elizabeth Roper, boasts extensive experience in the life sciences and venture capital sectors. Roper, with a background at The Wellcome Trust and Atlas Ventures, plays a pivotal role in shaping early-stage opportunities into successful companies. For startups looking to partner with Epidarex, it's crucial to demonstrate strong scientific foundations, clear commercialization pathways, and the potential for outstanding financial returns and patient benefits​.

Episode 1 Ventures, based in London, specializes in early-stage investments in technology companies across the UK. Founded in 2013, the firm focuses primarily on B2B software sectors, including AI, health tech, and software infrastructure. Their portfolio boasts notable investments such as Carwow, Triptease, and AimBrain. Episode 1 Ventures has recently launched a £76 million investment fund to support the next generation of tech startups. This fund is their largest yet and aims to provide substantial support to early-stage B2B firms, reflecting their commitment to fostering innovative UK-based companies​. The firm’s investment strategy typically involves making initial investments ranging from £250,000 to £3 million, guiding startups towards successful Series A rounds. They emphasize a hands-on approach, providing operational expertise and strategic guidance to help startups scale​. Key team members include Simon Murdoch, Adrian Lloyd, and Damien Lane, who bring extensive experience in entrepreneurship and investment. Their combined expertise ensures that Episode 1 Ventures can offer not just financial support, but also valuable mentorship and industry insights to their portfolio companies.

EQT Ventures is a powerhouse in the venture capital world, renowned for its robust investment portfolio and strategic prowess. The fund, managing €1.1 billion, focuses on early-stage tech startups, primarily in Europe and North America. Notable investments include Wolt, Peakon, and Airkit, showcasing its knack for backing high-potential companies. EQT Ventures targets industries like fintech, health tech, AI, mobile gaming, and sustainability. The fund is particularly interested in business models with scalable tech solutions that address real-world problems. Geographically, EQT Ventures has a strong presence in Europe and the US, with offices in major hubs like Stockholm, London, Berlin, Paris, and San Francisco. This broad reach helps them tap into diverse markets and innovation ecosystems. Their investment strategy is both aggressive and supportive, offering initial investments ranging from €1 to €50 million. EQT Ventures is known for its active involvement in scaling startups, leveraging a team of over 40 founders and operators. The advisory team, split equally between men and women, uses proprietary AI tools like Motherbrain to identify and nurture high-growth opportunities. Founders can expect a hands-on approach, with EQT Ventures providing not just capital, but also strategic guidance and operational support. The team, led by key figures like Lars Jörnow and Ashley Lundström, brings a wealth of experience and a track record of success in building global companies.

Esco Ventures, the investment arm of Singapore-based Esco Group, focuses on early-stage life sciences and medtech startups. The firm specializes in areas like biotech, diagnostics, and women’s health, aiming to nurture groundbreaking technologies that improve global health. What sets Esco Ventures apart is its hands-on approach, offering startups more than capital by providing mentoring, productization, manufacturing support, and global distribution networks through its parent company, Esco Group. Esco Ventures plays a crucial role in shaping the next wave of medical innovations, drawing on Esco Group’s decades of experience in life sciences. Their investment philosophy is built around long-term growth, with an emphasis on addressing unmet medical needs through disruptive technologies. The firm has a global reach but maintains a particular focus on Singapore, aligning with the nation’s vision to become a biomedical innovation hub in Asia. Under the leadership of Managing Partner XiangQian Lin, Esco Ventures works closely with scientists, engineers, and entrepreneurs, guiding them from ideation to commercialization. The firm has already seen success with investments like a Danish/Lithuanian medical device company, which achieved 5x growth within three years. Esco Ventures also actively supports the local Singaporean ecosystem by mentoring early-stage researchers and startups even before formal incorporation, fostering a collaborative and innovative environment aimed at creating the next big breakthroughs in life sciences and medtech.

ET Capital, established in 1992, is a distinguished venture capital firm based in southern England, with a particular focus on the dynamic tech ecosystems around Cambridge, Oxford, and London. The firm has raised and managed a series of funds aimed at high-growth technology businesses within these globally significant clusters. Initially backed by HSBC and the European Investment Fund, ET Capital has since evolved into a key player in the UK’s venture capital landscape, particularly in the realms of life sciences, information technology, and green technology. The firm has a robust portfolio of over 40 companies, with notable successes like ADC Therapeutics, a biotech company that went public on the NYSE in 2020 with a valuation of $1.3 billion. ET Capital also plays a pivotal role in the climate tech space through its management of the Carbon13 SEIS Funds, which invest in startups dedicated to addressing the climate emergency. These funds are closely linked to the Carbon13 venture builder, a Cambridge-based initiative that fosters innovative companies focused on significant carbon emission reductions. Led by Managing Director Martin Rigby, who brings over 30 years of experience in early-stage technology investments, ET Capital is known for its deep expertise in nurturing innovative tech companies from inception to success. The firm’s investment strategy is characterized by a strong emphasis on early-stage, science-based businesses with the potential to scale globally. ET Capital’s partnerships extend internationally, including ventures like the UK China Enterprise, which supports science-based businesses aiming to expand into the Chinese market​.

ETF Partners (Environmental Technologies Fund) is a leading European venture capital firm focused on sustainability and impact investing. Founded in 2006 and based in London, ETF Partners invests in companies that are developing innovative technologies to address the global climate crisis. Their portfolio spans sectors such as smart energy, sustainable cities, and resource efficiency, supporting startups that align profit with environmental impact. With a mission to foster sustainable innovation, ETF Partners has raised multiple funds, the latest being a €285 million fund oversubscribed in 2024. This fund invests in fast-growing companies like Fairly Made, Hellas Direct, and Dexter, all of which are working to solve pressing environmental challenges. The firm is backed by major institutions like the European Investment Fund and British Patient Capital, further highlighting its credibility in the space. ETF Partners takes a hands-on approach, working closely with entrepreneurs to help scale their businesses and ensure they achieve both commercial success and environmental impact. By supporting startups at various stages, from seed to growth, the firm aims to drive systemic change in the fight against climate change, while achieving strong financial returns for investors.

Eurazeo is a prominent global investment group with approximately €35 billion in assets under management, including €24 billion managed on behalf of institutional and private clients. The firm specializes in private equity, private debt, and real assets, with investments spanning consumer, healthcare, tech-enabled services, and financial services sectors. Notable investments include high-profile companies like Moncler, Farfetch, Vestiaire Collective, Asmodee, and Orolia, as well as tech companies like Deezer and Onfido. Eurazeo’s strategy focuses on identifying and accelerating the growth potential of their portfolio companies through capital investment and strategic support. Eurazeo operates across various investment strategies, including buyouts, growth capital, venture capital, and real assets. With offices in Europe, North America, and Asia, Eurazeo has a diverse geographic reach and is committed to long-term value creation with a responsible investment approach.

Eureka! Venture SGR, established in 2019, is Italy's first independent venture capital firm focusing exclusively on deep tech investments. Based in Milan and Rome, Eureka! specializes in transformative technologies, including AI, energy, health and well-being, mobility, and environmental innovations. The firm manages Eureka! Fund I, a technology transfer fund designed to bridge the gap between scientific discovery and commercial success. With a focus on startups born from cutting-edge research, Eureka! aims to foster the development of deep tech solutions that have the potential to revolutionize industries. Their portfolio includes startups like BeDimensional (nanotechnology) and ReHouseIt (sustainable construction), reflecting their commitment to impactful innovation. Eureka! also adheres to strict ESG (Environmental, Social, Governance) principles, aligning their investments with the UN's 2030 Sustainable Development Goals. The firm’s leadership, including CEO Stefano Peroncini and co-founder Anna Amati, brings over 25 years of experience in venture investing and technology transfer. This expertise enables them to guide startups from initial innovation to market, leveraging strategic partnerships with universities and research institutions across Europe. In addition to deep tech, Eureka! operates the BlackSheep Fund, which invests in late-stage European tech companies transforming the marketing industry through AI and big data.

The European Circular Bioeconomy Fund (ECBF) is a specialized venture capital fund dedicated to driving the transition from a fossil-based to a bio-based economy in Europe. Established in 2020 and headquartered in Luxembourg, ECBF was initiated with support from the European Union to fill a critical funding gap identified in the growth phase of bioeconomy companies. The fund, managed by Hauck & Aufhäuser Funds Services S.A. and advised by ECBF Management GmbH, has raised €300 million, surpassing its initial target of €250 million. ECBF focuses on investing in growth-stage companies that contribute to the circular bioeconomy, aiming to support innovative entrepreneurs whose technologies can revolutionize industries and promote sustainability. The fund's portfolio includes companies across various sectors such as bio-based materials, agritech, and bioplastics. ECBF's investments align with the European Green Deal goals, particularly the aim to make Europe climate neutral by 2050. The fund's approach combines financial support with strategic guidance, leveraging a diverse and experienced team to help portfolio companies achieve both environmental impact and favorable financial returns. Investors in ECBF include a mix of public and private entities from across Europe, reflecting broad support for advancing the bioeconomy sector.

EV Private Equity is a Norwegian venture capital firm dedicated to decarbonizing the energy sector through strategic investments in cutting-edge energy technology companies. With offices in Stavanger, Norway, and Aberdeen, UK, EV Private Equity manages a robust portfolio of 16 companies across Europe and North America. They focus on high-growth, technology-driven firms that demonstrate substantial potential for reducing greenhouse gas emissions and improving energy efficiency. Their investment strategy targets companies in the growth stage with experienced management teams, scalable business models, and differentiated technology offerings. EV Private Equity has committed to a significant environmental impact, aiming to remove one tonne of CO2e for every €300 invested. This rigorous approach is backed by third-party assessments of their impact achievements, ensuring transparency and accountability. Notable investments include Bluware, a leader in seismic data interpretation, and Trainor Group, a digital electrical safety training provider. Both companies have seen substantial growth under EV Private Equity's guidance, culminating in successful exits to larger strategic acquirers. Key team members, such as Senior Partner Rune Jensen, bring extensive industry experience and leadership, fostering a culture of innovation and sustainability. Startups seeking investment should demonstrate strong environmental impact potential and a clear path to scalable growth. EV Private Equity prefers to be approached with detailed, impact-oriented proposals that align with their mission of driving the energy transition.

Eversource Capital is a Mumbai-based impact investment firm that focuses on climate change mitigation and sustainable infrastructure. It is a joint venture between Everstone Group and Lightsource bp, with a strong emphasis on renewable energy, e-mobility, waste management, and water sustainability. Eversource’s flagship fund, the Green Growth Equity Fund (GGEF), closed with $741 million, exceeding its target. The firm actively invests in green infrastructure and technologies that help reduce carbon emissions and promote sustainable economic growth, aiming to support India's decarbonization efforts. Their portfolio includes companies like Ayana Renewable Power, focused on utility-scale renewable energy, and GreenCell Mobility, which provides sustainable e-mobility solutions in India. Eversource also invests in innovative green finance and energy transition projects to promote cleaner energy alternatives. The leadership team, including Dhanpal Jhaveri, Anoop Poddar, and Vibhor Talreja, brings a wealth of experience in private equity and renewable energy investments. Their investment strategy prioritizes projects that deliver both financial returns and measurable environmental impact, aligning with their goal of combating climate change while fostering industrial decarbonization​.

Evok Innovations, founded in 2016 and headquartered in Vancouver, Canada, is a venture capital firm focusing on early-stage investments in clean technology and energy transition solutions. The firm primarily targets technologies that address critical industrial decarbonization challenges, including carbon capture, low-carbon fuels, clean energy, and advanced materials. Evok Innovations has a diverse portfolio with notable investments in companies such as Twelve, which develops carbon transformation technologies, and Quidnet Energy, a company specializing in long-duration energy storage. They recently led a $58.4 million Series B funding round for ZwitterCo, an environmental technology firm, and a $31 million Series A round for e-Zinc, which focuses on energy storage solutions. The firm launched its second fund, Evok Fund II, with a $300 million close in 2022, attracting significant participation from major financial institutions like Export Development Canada, Royal Bank of Canada, and The Toronto-Dominion Bank. This new fund continues to focus on accelerating the development of clean technologies across North America. Led by partners Marty Reed, Mike Biddle, Naynika Chaubey, and Jane Kearns, Evok Innovations combines deep technical expertise with a strong network to support the growth and scaling of its portfolio companies.

Evolution VC Partners is a New York-based venture capital firm focused on "culture-tech" investments—companies that are reshaping how people work, live, and interact with technology. Established by Gregg Smith, the firm primarily invests in sectors such as advanced materials, 3D printing, fintech, media, entertainment, digital health, life sciences, and plant-based innovations. Their goal is to support disruptive companies that are defining today's culture and paving the way for future societal shifts. The firm is stage-agnostic, meaning it invests in companies at various phases, from early-stage to growth-stage ventures. Evolution VC Partners works closely with founders, providing not just capital but also strategic advice to accelerate growth. Their portfolio includes notable companies like Instacart, Rodo, DailyPay, and Axiom Space. What sets Evolution apart is that it operates solely with the founder's personal capital, allowing for more flexibility and focus on long-term impact rather than external fund performance​.

Evolv Ventures is a venture capital firm based in Chicago, founded in 2018 by Kraft Heinz with a $100 million fund to invest in emerging technologies that are transforming the food industry. The fund is particularly focused on early-stage startups in sectors like food technology, retail technology, consumer products, and digital logistics. Evolv Ventures leverages Kraft Heinz’s extensive network, industry expertise, and resources to support the growth of its portfolio companies, positioning itself as a value-added investor in the food tech space. The firm is led by seasoned venture investor Bill Pescatello, who brings a wealth of experience from previous roles at Lightbank and GE Capital. Notable investments by Evolv Ventures include companies like New Culture, which is developing animal-free dairy products, and Zippin, a startup focused on checkout-free retail technology. By combining financial backing with strategic support, Evolv Ventures aims to drive significant innovation and disruption within the food industry, ultimately aligning with Kraft Heinz’s broader goals of staying at the forefront of food innovation.

Evonik Venture Capital, the corporate venture arm of Evonik Industries, manages a fund size of €400 million and has made over 50 investments since 2012. The firm strategically invests in innovative startups across various growth fields such as Nutrition & Care, Smart Materials, Specialty Additives, and Digitalization, with a strong focus on sustainability and carbon neutrality technologies​. Evonik's portfolio includes startups like Interface Polymers, which develops additives for easier recycling of plastics, and SuperC, a leader in graphene materials for improving lithium-ion batteries. Other notable investments are Allay Therapeutics, which has developed a post-surgery pain relief implant, and Citrine Informatics, an AI-driven platform for materials and chemicals development​. The venture capital unit emphasizes early to growth-stage investments, with typical investment volumes of up to €15 million per portfolio company. They aim to be an active partner, providing strategic, technical, and commercial support, and leveraging their extensive network for the growth of their portfolio companies. Evonik Venture Capital operates globally with offices in Germany, the USA, and China, making them well-positioned to support innovative startups in key regions worldwide.

Excalibur Group Holdings, based in London, is a venture capital firm with a strong focus on life sciences, biotechnology, and medical devices. Established in 1996, the firm has built a reputation for bridging the gap between research and commercialization, providing both early and late-stage capital. Excalibur plays an active role in developing cutting-edge therapies, diagnostics, and healthcare technologies. Their investment strategy targets companies that are innovating in critical areas such as oncology, therapeutic devices, and laboratory services. The firm has made over 59 investments, with notable companies like Celsis International, NeoGen, and Selah Genomics. Excalibur's investments span various stages, from early ventures to generating revenue, and their portfolio emphasizes transformative healthcare solutions. They have also facilitated numerous successful exits, including companies like Plethora Solutions and Celsis In Vitro. Excalibur's approach is highly strategic, supporting startups not just with capital but also by offering market access and strategic advice, positioning them for acquisitions or public listings. This makes Excalibur a critical player in the European life sciences venture space, known for its ability to take healthcare innovations from the lab to the marketplace.

Excel Venture Management, founded in 2007 and headquartered in Boston, Massachusetts, specializes in investing in transformative life science technologies. The firm’s portfolio spans healthcare IT, diagnostics, medical devices, and life science platforms, addressing a broad array of industries including agriculture, energy, and defense. Notable investments include InfoBionic, Aileron Therapeutics, and Molecular Templates. Excel's strategy focuses on early to late-stage investments, typically ranging from $1 million to $5 million. They avoid single-molecule drugs, preferring platform technologies that offer multiple exit scenarios and applications across diverse market sectors. The firm's holistic approach involves extensive due diligence, strategic guidance, and leveraging a global network of resources to drive portfolio companies towards leadership positions in their fields. The team, led by key figures like Jeanne Henry (CFO) and Juan Enriquez (Managing Director), brings a wealth of experience in venture capital, financial management, and life sciences. They work closely with entrepreneurs to refine corporate strategies, develop value-driven milestones, and facilitate customer and partner introductions, ultimately aiming for successful exits through acquisitions or IPOs. Excel Venture Management has been instrumental in the success of companies like ClearDATA, Cleveland HeartLab, and Synthetic Genomics, showcasing their commitment to driving innovation in the life sciences sector and beyond​.

Excell Partners is a prominent venture capital firm based in Rochester, New York. Established in 2006, it focuses on seed-stage investments, primarily targeting high-tech, high-growth startups in Upstate New York. Excell Partners is an affiliate of the University of Rochester and manages over $40 million in assets, having invested in 60 companies across various sectors including medical devices, materials, energy, biotech, agtech, imaging, and IT/software. Under the leadership of CEO Theresa Mazzullo, Excell Partners emphasizes a hands-on approach, providing not only capital but also extensive support through strategic guidance, a broad network of professionals, and long-term partnership commitments. Their investment strategy includes maintaining "dry powder" for follow-on funding to ensure continuous support for portfolio companies as they scale. Excell Partners also manages the $25 million Finger Lakes Forward Venture Capital Fund, which supports regional strengths in optics, imaging, photonics, food and agriculture, life sciences, and advanced manufacturing. This fund aims to boost economic growth in the Greater Rochester area by increasing access to capital for high-tech startups. Notable investments include RealEats, a prepared meal delivery service, and Owl Autonomous Imaging, which focuses on advanced thermal sensor technologies. Excell Partners is dedicated to fostering innovation and economic development in the Finger Lakes region, leveraging the area's academic and research strengths to nurture promising startups and retain local talent.

Exor N.V. is a prominent European investment company headquartered in Amsterdam, Netherlands, controlled by the Agnelli family. Established in 1927, Exor's portfolio is diverse, encompassing various industries such as automotive, luxury goods, media, and healthcare. Key holdings include significant stakes in well-known companies such as Ferrari, Stellantis, and CNH Industrial. Exor owns 22.9% of Ferrari, making it a crucial player in the luxury sports car market. Stellantis, one of the world's leading automakers, also forms a significant part of their portfolio with brands like Fiat, Chrysler, and Peugeot. CNH Industrial, involved in agricultural and construction equipment, is another major investment. In the media sector, Exor holds a substantial share in The Economist Group, owning 43.4% of its economic rights. They also have a significant investment in GEDI Gruppo Editoriale, a major Italian media conglomerate, holding 89.6% of the economic rights. Exor's investment strategy focuses on long-term value creation, often involving active participation in the management of their portfolio companies to drive growth and innovation. This approach is evident in their diversified and strategically selected investments across various sectors.

Expa, founded by Garrett Camp in 2013, is a venture studio and VC fund based in San Francisco. It focuses on early-stage investments, particularly in SaaS, FinTech, ClimateTech, E-Commerce, and software sectors. Notable investments include companies like Aero, Current, Collective, Metabase, and Joro. With over 100 investments and 11 exits, Expa typically provides seed funding between $500K and $1M and plays an active role in guiding startups through MVP development, hiring, and finding product-market fit. Expa’s strategy is centered around supporting founders with both capital and hands-on expertise. They value strong, innovative ideas and prefer to be approached with detailed, well-structured pitches demonstrating clear market potential. Their global reach includes significant investments across the U.S., with key operations in San Francisco​​. The Expa team, featuring industry leaders and experienced entrepreneurs, ensures robust support for their portfolio companies. For those looking to engage with Expa, networking through industry events and leveraging mutual connections can be effective ways to gain their attention.

Expansion Venture Capital, also known as Expansion VC, is a prominent early-stage venture capital firm focused on investing in pre-seed, seed, and select Series A stage technology companies. Founded by brothers Joseph and Ryan Melohn, the firm operates primarily out of New York City and Miami. Expansion VC's portfolio boasts a range of successful companies across various sectors, including notable investments in ClassPass, Turo, Carta, Lemonade, The RealReal, Allbirds, and Firebase. These investments span industries such as fintech, proptech, digital health, and consumer technology. The firm is known for its hands-on approach, providing not just capital but also strategic support in areas like mentorship, customer acquisition, talent sourcing, and securing partnerships. The firm prides itself on building long-term relationships with its founders, offering around-the-clock support to help navigate challenges and drive growth. Expansion VC has a reputation for leveraging its extensive network to accelerate the success of its portfolio companies by facilitating key introductions and securing strategic guidance.

Exponential Impact is an accelerator and incubator focused on early-stage companies in Colorado. Based in Colorado Springs, Exponential Impact supports startups through funding, mentorship, and a robust network aimed at driving economic development and innovation in the region. The organization provides a variety of programs tailored to different stages of a startup's journey, from initial idea validation to scaling operations​. Their portfolio includes companies across diverse sectors, particularly those leveraging technology to create significant social and economic impact. The firm emphasizes the importance of digital assets and distributed ledger technology in fostering inclusive economic growth​​. For startups looking to engage with Exponential Impact, demonstrating a clear mission to expand human potential and alleviate suffering through innovative solutions can be advantageous. Their integrated support model, which includes advisory, capital raising, and access to market services, provides a comprehensive framework to help startups thrive​.

ExSight Ventures is a New York City-based life sciences venture capital firm founded in 2014, specializing exclusively in early-stage ophthalmic diagnostic and treatment solutions. The firm was co-founded by James Murray alongside Dr. Michael Nissen, a retinal surgeon on faculty at Weill-Cornell Medical Center since 1998, and Dr. Firas Rahhal, also a retinal surgeon. The team of eight partners combines deep clinical domain expertise with investment and legal experience, including Murray's role as Chair of the Emerging Companies and VC Committee at the NYC Bar Association. ExSight raised its fourth fund in 2025, marking continuous growth since founding. The firm leads rounds and deploys checks from $250K to $4 million, investing from Seed through Series B in companies across North America. With 21 investments to date, notable portfolio companies include Horizon Surgical Systems, for which ExSight led a $30 million Series A in October 2024 in a robotics and AI surgical platform; ONL Therapeutics, which raised $65 million in a Series D alongside J&J Innovation; Re-Vana Therapeutics; Envision Diagnostics; Trefoil Therapeutics; LensGen; and Valitor Bio. Three portfolio companies have been acquired: DTx Pharma by Novartis, RetroSense Therapeutics by Allergan, and ELIOS Vision by Bausch & Lomb in December 2024. ExSight's thesis holds that ophthalmology is an ideal venture investment domain due to its massive and growing global market, insufficient current standards of care, a robust innovation pipeline, and the eye's unique anatomy as a proving ground for breakthrough technologies including gene therapy, AI diagnostics, and surgical robotics. The firm's clinical founders give it a differentiated vantage point for evaluating scientific merit, clinical feasibility, and commercial potential simultaneously.

Extantia Capital is a Berlin-based venture capital firm dedicated to accelerating decarbonization through early-stage investments in climate technology. With over €100 million in assets under management, Extantia focuses on scalable deep decarbonization solutions that have the potential to significantly reduce global carbon emissions. The firm employs a "carbon math exclusion principle," investing only in startups that can abate at least 100 million tonnes of CO2 annually when fully scaled. This strategy directs them towards hardware-based innovations in sectors such as energy, carbon removal, transportation, and industrial processes. Extantia operates through two main funds: Flagship, which backs transformative companies like INERATEC (e-fuels) and Reverion (biogas energy), and Allstars, which invests in other climate-focused venture funds. Their portfolio includes 12 companies, many of which focus on hard-to-abate sectors using technologies like direct air capture and green hydrogen production. The firm’s approach to building successful ventures is deeply rooted in strong founding teams, balancing technical expertise with commercial acumen. Extantia looks for co-founders who can work collaboratively across disciplines, ensuring that both the technological and business aspects of their startups are well-aligned. Looking forward, Extantia anticipates that the next generation of unicorns will emerge from the climate tech space. They are particularly excited about trends like green ammonia and the sustainable mining of raw materials, which are critical for the energy transition. Extantia is positioning itself at the forefront of this shift, creating opportunities for both significant climate impact and financial return.

F-Prime Capital is a global venture capital firm that focuses on investing in healthcare and technology. With roots tracing back to Fidelity Investments, F-Prime Capital has a long history of supporting innovative companies and fostering entrepreneurship. The firm has invested in over 290 companies across various stages and sectors, with notable investments in companies like Alibaba, Moderna, and Affinia Therapeutics. F-Prime Capital's investment portfolio spans a range of industries including therapeutics, enterprise IT, fintech, and medtech. For instance, Affinia Therapeutics is working on developing transformative gene therapies, while Alibaba is a major player in the e-commerce sector. The firm has also been involved in companies like Airespace, which was acquired by Cisco, and AlphaGen Therapeutics, focusing on radiopharmaceuticals. The firm's approach includes investing in early-stage companies and supporting them through their growth phases with both capital and strategic guidance. F-Prime Capital emphasizes the importance of innovation and has been a significant player in advancing new technologies and solutions within its focus areas.

F2 Venture Capital is a Tel Aviv-based venture capital firm focused on early-stage investments, particularly at the intersection of big data, artificial intelligence (AI), and connectivity. Founded to support visionary entrepreneurs, F2 backs startups from pre-seed through Series B, offering not just capital but also strategic guidance and operational support to help founders scale their businesses effectively. F2's portfolio is diverse, with investments in companies across sectors like AI, healthcare, and enterprise solutions. Some notable companies backed by F2 include Explorium, a data science platform, Parametrix, an AI-powered monitoring service for cloud infrastructure, and Justt, which provides fraud prevention for online transactions. F2 is also known for its deep involvement in Israel’s vibrant tech ecosystem and runs "The Junction," a pre-seed program designed to help startups grow from day one. With a strong focus on empowering founders, F2 Ventures combines its industry expertise and global network to help startups succeed in highly competitive markets. The firm operates with a "radically founder-focused" approach, ensuring personalized support for its portfolio companies at every stage of their development.

Fall Line Capital, founded in 2011 and headquartered in San Mateo, California, specializes in investing in farmland and agricultural technologies. The firm combines expertise in venture capital with deep knowledge of agriculture to support innovative early-stage companies. Fall Line Capital’s portfolio includes notable investments in companies such as Impossible Foods, which produces plant-based meat substitutes; GreenLight Biosciences, focusing on RNA-based solutions for agriculture and human health; and Planet Labs, which provides satellite imagery for various applications. Other significant investments include FarmWise, known for its vision-based automation systems, and Trace Genomics, which offers soil diagnostics technology. The firm also actively manages farmland across the United States, leveraging this experience to add value to its tech investments by testing new products on their land. This unique strategy allows Fall Line to function both as a traditional venture investor and a strategic partner, providing a robust support system for their portfolio companies.

Far East Ventures is the venture capital arm of Far East Organization, one of Singapore's largest private real estate developers. Founded in January 2014 by brothers Edward Ng, Jonathan Ng, and Graham Ng, the firm operates as a corporate venture capital and family office vehicle investing in visionary entrepreneurs building disruptive technologies. Edward and Jonathan Ng are based in Palo Alto, California, with Jonathan having studied at Stanford University, while Graham Ng manages operations from Singapore. The firm evaluates investments purely on merit, with no requirement that portfolio companies generate strategic value for the parent organization. Far East Ventures invests across all stages from seed to growth, writing checks typically between $1 million and $5 million, with reported maximum deal sizes up to $30 million. The firm focuses on the United States, Southeast Asia, and China across technology, healthcare, medtech, foodtech, software, and real estate. Notable portfolio companies include StaffAny, a workforce management platform that raised a Series A in January 2022; One Zero, a digital bank; and Sealed Network, a business productivity platform. The firm has executed more than 30 investments across multiple regions. Far East Ventures applies a data-driven methodology with an operator-first philosophy, leveraging the founding family's deep understanding of Asian markets and their long track record of capital allocation through Far East Organization. The firm's dual base in Silicon Valley and Singapore gives it a meaningful vantage point for identifying technology companies well positioned to grow across both the US and Asia-Pacific markets.

Planet 9 Venture is an early-stage venture capital firm founded in 2016 by the Norwegian Odfjell family — a dynasty with more than a century of operating history in global shipping — under the Farvatan Group. Headquartered in Bergen, Norway, the firm is owned by Johan Odvar Odfjell and has historically invested across two signature verticals: ocean economy and life sciences, with a geographic focus on the Nordic countries and Silicon Valley. In 2023, Planet 9's operations were absorbed and rebranded under the Farvatn Venture umbrella, with the combined entity expanding into renewable energy and broader ocean-tech alongside its original life-science mandate. Across the combined Planet 9 and Farvatn history, 92 investments have been made — 21 under the historical Planet 9 banner. Notable historical portfolio companies include Evoy (electric maritime propulsion), Molofeed (aquaculture), Sapiens Data Science, Aivero (which raised NOK 16 million from Planet 9 Venture alongside Valinor, Vyrd, and Stratel), Modsy (home design), Dynaspace, and TerViva. Under the Farvatn brand, recent activity includes investments in Scindo, Noteless, Nowwell, Ocean Oasis, and GattaCo Inc. One disclosed exit was completed for Shifter. The firm operates with a small two-person partner team and maintains investment activity across both Norway and the United States, positioning itself as a bridge between the Nordic deep-tech ecosystem and Silicon Valley capital networks. Its roots in the Odfjell shipping legacy give Planet 9 genuine industrial credibility in ocean-economy sectors, while its expansion into life sciences and clean energy reflects the broader Farvatn platform's long-term view of where sustainable industrial value will be created.

FST Ventures is a venture capital firm with a strong focus on early-stage investments in technology and fintech sectors. Founded by Victor Jiang, FST Ventures emphasizes a proactive management approach to mitigate investment risks. This involves securing board seats and getting actively involved in strategic and operational aspects of their portfolio companies, from cash flow management to strategic market entry and forming new partnerships. The firm's investment strategy is highly customer-centric, particularly in online marketplaces, where they prioritize informed self-service and robust cybersecurity measures. They aim to create a holistic value chain across their investments, ensuring comprehensive support and integration into the companies they back. FST Ventures is globally oriented, making strategic investments in diverse markets including North America, Europe, Asia, and Latin America. This geographic diversification allows them to dynamically allocate capital and resources based on market conditions and opportunities. Their portfolio includes investments in companies that leverage innovative technologies to disrupt traditional markets and create significant value. By focusing on sectors like business and financial services, healthcare, industrial, retail, and technology, FST Ventures aligns its investments with long-term growth and sustainability.

FastTrack VC is a global co-investment platform founded in 2015 and based in Whistler, British Columbia, Canada, founded and led by CEO Ruben Dias, a serial technology entrepreneur with over twenty years of experience. The platform enables accredited investors and other funds to co-invest in hand-selected early-stage technology startups from around the world, with individual investors able to participate in deals for as little as $10,000. FastTrack focuses on seed-stage investments up to $1 million and receives approximately 100 startup applications per month, with roughly 10% advancing to further consideration. FastTrack has made approximately 8 investments across software, biotech, healthtech, and AI. Its first major co-investment campaign raised $1.9 million CAD for Monarch Bioimplants, a Swiss biomedical company developing chitosan-based medical devices. Dias brings a personal track record that includes successful exits with industry partners including Panda Security, Tyco International, and SolarWinds. Investments span Canada, Europe, and the United States, reflecting the platform's global sourcing mandate. FastTrack VC's model is built on the premise that access to high-quality venture deal flow should not be limited to institutional funds. By pooling capital from accredited investors alongside institutional co-investors, the platform broadens participation in early-stage technology companies while maintaining a curated selection process driven by Dias's entrepreneurial judgment and network.

Fearless Ventures is a venture capital firm dedicated to helping entrepreneurs develop both impactful businesses and conscious leadership skills. Co-founded by Seth Miller, a former partner at DBL Investors, and Dave Kashen, a seasoned entrepreneur and CEO coach, Fearless Ventures brings a unique approach to investing. The firm emphasizes leadership training alongside financial backing, offering portfolio companies access to CEO coaching, leadership workshops, and mental well-being support. This focus on personal development aligns with the firm’s broader mission to create value for all stakeholders, not just shareholders​. Fearless Ventures typically invests in early- to growth-stage companies across a range of industries, including fintech, medtech, healthcare, and SaaS. The firm operates with a flexible investment approach, adjusting its ticket sizes and investment timelines to match the needs of the startups it backs. Their investments aim to support businesses with a sustainable, long-term outlook, fostering innovation that benefits communities and society as a whole. A distinctive aspect of Fearless Ventures is their integration of conscious leadership into the fabric of their investments. Founders in their portfolio undergo intensive leadership coaching, which is designed to not only grow the business but also develop the emotional and mental resilience needed to navigate the challenges of scaling a startup. The firm believes this holistic approach results in better-run companies and ultimately leads to stronger financial performance

Felicis Ventures, based in Menlo Park, California, is renowned for backing transformative companies across various stages and sectors. Notable investments include Canva, Gusto, Guild Education, Komodo Health, and Matterport. They focus on frontier tech, health and bio, security, vertical SaaS, and AI. With a global investment approach, Felicis leads rounds and offers substantial support to founders. Their average check size varies but is known to be significant in leading investments. Key team members like Sundeep Peechu bring deep expertise from backgrounds in tech and venture capital. Approaching Felicis involves demonstrating high-risk, high-reward potential and a clear narrative aligning with their visionary outlook.

ff Venture Capital (ffVC) is a New York-based venture capital firm, founded in 2008 by John Frankel and Alex Katz. The firm specializes in seed and early-stage investments across sectors such as AI, fintech, insurtech, drones, and robotics. With over 90 active portfolio companies, ffVC is known for its strategic investments and support for startups in emerging industries. Some of ffVC's notable investments include companies like Addepar, Cornerstone OnDemand, Indiegogo, Ionic Security, Skycatch, Plated, Owlet, and Socure. These investments highlight ffVC's focus on innovative technologies and their potential to transform industries. The firm typically invests with an average check size of over $500,000, leading or following in funding rounds to provide substantial support to its portfolio companies. ffVC has also expanded its operations globally, with a significant presence in Europe, particularly through its ff Red & White fund, which supports startups in Central Europe. This expansion demonstrates ffVC's commitment to driving innovation and supporting entrepreneurial ventures on an international scale. The firm places a strong emphasis on building a robust community around its investments, actively partnering with founders to create high-value, market-moving businesses. This approach is further strengthened by its strategic hires and collaborations, enhancing its operational capabilities and global reach.

FFG Venture Business Partners is a corporate venture capital firm founded in 2016 as a wholly owned subsidiary of Fukuoka Financial Group (FFG), one of Japan's leading regional banking groups. Headquartered in Fukuoka, Japan, the firm serves as FFG's dedicated venture investment arm, leveraging the financial group's extensive banking network and institutional resources to support innovative startups across Japan and Asia-Pacific. The team comprises approximately 22 to 29 professionals including six to eight partners. The firm has built a portfolio of over 150 investments, one of the largest CVC portfolios in Japan. Typical check sizes range from $1 million to $5 million, with investments spanning Seed through Series B stages across fintech, AI and deep tech, life sciences, biotech, robotics and IoT, energy, space technology, consumer services, and mobility. Notable portfolio companies include Capsule, Neusignal Therapeutics, ACCELStars, Feliqs, and KaKa Creation. The firm has completed approximately 10 portfolio exits, with the most recent being J-Pharma in March 2026. As a CVC backed by a major regional financial institution, FFG Venture Business Partners brings strategic banking relationships, corporate governance expertise, and access to FFG's extensive corporate client base to its portfolio companies. This is particularly valuable for startups seeking commercial adoption within Japanese enterprises or financial institutions, and for companies planning eventual public listings in Japanese capital markets where FFG's networks provide meaningful structural advantage.

Fifty Years is a pre-seed and seed-stage venture capital firm based in San Francisco. Founded in 2015 by Ela Madej and Seth Bannon, Fifty Years focuses on backing founders who leverage technology to solve some of the world’s biggest challenges, such as climate change, disease, and malnutrition. The firm has a strong mission-driven investment approach, supporting companies that aim to achieve significant societal impact while also being massively profitable. The firm's portfolio includes innovative companies like Upside Foods (cell-based meat), Solugen (decarbonizing the chemicals industry), and Opentrons (affordable robots for biologists). Fifty Years has invested in a variety of sectors including biotechnology, food technology, and advanced manufacturing. The leadership team is comprised of experienced entrepreneurs and investors, with Ela Madej bringing her extensive background as a serial tech entrepreneur and Y Combinator alum. Fifty Years emphasizes helping scientists and engineers become successful entrepreneurs, providing not only capital but also strategic guidance and support.